Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Diwakar Davar

Melanoma · UPMC Mercy

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Rebecca Miksad

GI Oncology · BMC

View

Dr. Lee Scheinbart

General Oncology · Burrell College of Osteopathic Medicine

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    SCDr. Sunandana Chandra
    Leading Voice

    Dr. Sunandana Chandra

    Medical Oncology · Melanoma Oncology
    Northwestern University
    sunandana

    Research

    Contemporary Management of Merkel Cell Carcinoma

    2026

    Via Hematology/Oncology Clinics of North America

    Research

    Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma

    2025

    Via The British Journal of Dermatology

    Research

    Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1-Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma

    2025

    Via Clinical Cancer Research

    Research

    Real-world outcomes in patients with melanoma brain metastasis: a US multisite retrospective chart review study of systemic treatments

    2025

    Via BMJ Open

    Research

    Proceedings of the seventh annual Women in Melanoma Conference

    2025

    Via Therapeutic Advances in Medical Oncology

    Research

    Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors

    2025

    Via Journal for Immunotherapy of Cancer

    Research

    Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management

    2025

    Via Journal of the American Academy of Dermatology

    Research

    HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors

    2025

    Via Future Oncology

    Research

    Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial

    2025

    Via Nature Medicine

    Research

    Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study

    2025

    Via EClinicalMedicine

    Research

    Metastatic Merkel Cell Carcinoma: Efficacy and Tolerability of Systemic Therapy

    2024

    Via Seminars in Oncology

    Research

    Anatomic Subtype Differences in Extramammary Paget Disease: A Meta-Analysis

    2024

    Via JAMA Dermatology

    Research

    NCCN Guidelines Insights: Melanoma: Cutaneous, Version 2.2024

    2024

    Via Journal of the National Comprehensive Cancer Network

    Research

    Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications

    2024

    Via Journal of Clinical Oncology

    Research

    Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy

    2024

    Via Cancer Discovery